Azenta, Inc. (LON:0HQ1)
| Market Cap | 1.03B -48.4% |
| Revenue (ttm) | 442.11M +2.7% |
| Net Income | -44.73M |
| EPS | -0.98 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 33.04 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 36 |
| Average Volume | 155 |
| Open | 30.39 |
| Previous Close | 29.16 |
| Day's Range | 28.16 - 30.39 |
| 52-Week Range | 25.12 - 47.18 |
| Beta | 1.34 |
| RSI | 38.95 |
| Earnings Date | Feb 4, 2026 |
About Azenta
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl... [Read more]
Financial Performance
In fiscal year 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.
Financial numbers in USD Financial StatementsNews
Azenta (AZTA): Evercore ISI Group Lowers Price Target but Maintains Rating | AZTA Stock News
Azenta (AZTA): Evercore ISI Group Lowers Price Target but Maintains Rating | AZTA Stock News
Azenta outlines 3% to 5% organic revenue growth and 300bps margin expansion for 2026 amid macro uncertainty
Jefferies Lowers Azenta (AZTA) Price Target, Maintains Buy Rating | AZTA Stock News
Jefferies Lowers Azenta (AZTA) Price Target, Maintains Buy Rating | AZTA Stock News
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
Azenta, Inc. (AZTA) Q1 2026 Earnings Call February 4, 2026 8:30 AM ESTCompany ParticipantsYvonne Perron - Vice President of Financial Planning &...
Q1 2026 Azenta Inc Earnings Call Transcript
Q1 2026 Azenta Inc Earnings Call Transcript
Needham Reiterates "Buy" Rating for Azenta (AZTA) with $44 Price Target | AZTA Stock News
Needham Reiterates "Buy" Rating for Azenta (AZTA) with $44 Price Target | AZTA Stock News
Azenta Stock Falls 22% Over Wider Loss EPS In Q1
(RTTNews) - Stock of Azenta, Inc. (AZTA) is dropping about 22 percent on Wednesday morning trading following the announcement of its first quarter financial results, reporting loss of $0.34 per share ...
Azenta (AZTA) Q1 2026 Earnings Call Transcript
Azenta (AZTA) Q1 2026 Earnings Call Transcript
Azenta Earnings Review: Q1 Summary
Azenta (NASDAQ: AZTA) released its Q1 earnings on Wednesday, February 4, 2026 at 06:30 AM. Here's what's important from the earnings announcement. Earnings Azenta missed estimated earnings by -25.0%,...
Azenta: Q1 Earnings Insights
The earnings results for Azenta (NASDAQ: AZTA) for Q1 were made public on Wednesday, February 4, 2026 at 06:30 AM. Here's a comprehensive overview of the announcement. Earnings Azenta missed estimate...
Azenta Q1 Earnings Report: What Investors Need to Know
Azenta (NASDAQ: AZTA) announced its Q1 earnings on Wednesday, February 4, 2026 at 06:30 AM. Here's a breakdown of the earnings report. Earnings Azenta missed estimated earnings by -25.0%, reporting a...
Azenta reports mixed Q1 results; reaffirms FY26 outlook
Azenta press release (AZTA): Q1 Non-GAAP EPS of $0.09 misses by $0.04. Revenue of $149M (+1.4% Y/Y) beats by $1.9M. Organic revenue, which excludes the impact from foreign exchange,
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
BURLINGTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025.
Azenta Q1 2026 Earnings Preview
Azenta Inc Annual Shareholders Meeting Transcript
Azenta Inc Annual Shareholders Meeting Transcript
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
BURLINGTON, Mass., Jan. 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before t...
Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News
Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News
New Strong Sell Stocks for January 8th
AZTA, BCBP and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on January 8th, 2026.
AZTA: Evercore ISI Group Upgrades Rating and Raises Price Target | AZTA Stock News
AZTA: Evercore ISI Group Upgrades Rating and Raises Price Target | AZTA Stock News
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day
Vale stands out as Bull of the Day after a strong turnaround, rising production and a nearly 7% dividend push shares to new highs.
Bear of the Day: Azenta (AZTA)
2025 was another turbulent year for Azenta (AZTA) stock, which fell more than 30% as the medical solutions provider struggled with ongoing sales weakness.
New Strong Sell Stocks for December 30th
ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.
Azenta's Subsidiary To Sell B Medical Systems Business To THELEMA For $63 Mln
(RTTNews) - Azenta, Inc. (AZTA), Monday announced that its affiliate, Azenta Germany GmbH, has signed an agreement to sell its B Medical Systems business, a manufacturer and distributor of medical ref...
Azenta (AZTA) to Divest B Medical Systems for $63 Million
Azenta (AZTA) to Divest B Medical Systems for $63 Million
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical...